Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
67%(4 trials)
Terminated
1(13%)

Phase Distribution

Ph early_phase_1
1
13%
Ph phase_1
1
13%
Ph not_applicable
3
38%
Ph phase_4
1
13%
Ph phase_2
1
13%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
1(14.3%)
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(6)
Terminated(2)

Detailed Status

Completed6
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (14.3%)
Phase 11 (14.3%)
Phase 21 (14.3%)
Phase 41 (14.3%)
N/A3 (42.9%)

Trials by Status

withdrawn113%
completed675%
terminated113%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_4

Predicting Stroke Risk in ICAD With Novel MRI

NCT05515874
completedphase_2

Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI

NCT01336803
completednot_applicable

Investigation of Vascular Inflammation in Migraine Using Molecular Nano-imaging and Black Blood Imaging MRI

NCT02549898
terminatedphase_1

Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery

NCT02189889
completednot_applicable

Clinical and Technical Feasibility of a Ultrasuperparamagnetic Nanoparticle Iron Oxide (USPIO)-Enhanced Magnetic Resonance Lymph Node Imaging

NCT01815333
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT05515874Phase 4

Predicting Stroke Risk in ICAD With Novel MRI

Completed
NCT01336803Phase 2

Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI

Completed
NCT02549898Not Applicable

Investigation of Vascular Inflammation in Migraine Using Molecular Nano-imaging and Black Blood Imaging MRI

Completed
NCT02189889Phase 1

Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery

Terminated
NCT01815333Not Applicable

Clinical and Technical Feasibility of a Ultrasuperparamagnetic Nanoparticle Iron Oxide (USPIO)-Enhanced Magnetic Resonance Lymph Node Imaging

Completed
NCT01973517

High-Field MRI Iron-Based Contrast-Enhanced Characterization of Multiple Sclerosis and Demyelinating Diseases

Withdrawn
NCT02006108Not Applicable

Imaging Kidney Transplant Rejection Using Ferumoxytol-Enhanced Magnetic Resonance

Completed
NCT02466828Early Phase 1

qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia.

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8